Skip to main content


October 28, 2019
D. Tyler Coyle, MD, MS, of the University School of Medicine – Addiction Research and Treatment Services, dispels misconceptions around the safety of medications such as buprenorphine and methadone…
September 11, 2019
Anthony L. Rostain, MD, MA, discusses steps to take when treating attention-deficit/hyperactivity disorder (ADHD) in patients with hypertension or cardiovascular disease.
September 05, 2019
Anthony L. Rostain, MD, MA, discusses factors to consider when combining stimulants and nonstimulants in the treatment of attention-deficit/hyperactivity disorder (ADHD). 
September 04, 2019
For the past 10 years, the National Conference on Addiction Disorders has provided professionals with the tools they need to address unprecedented changes in the field of addiction.
August 26, 2019
When a patient is newly diagnosed with attention-deficit/hyperactivity disorder (ADHD), is it better to begin treatment with a stimulant or a nonstimulant? Anthony L. Rostain, MD, MA, shares his…
August 22, 2019
Rakesh Jain, MD, MPH, and Saundra Jain, MA, PsyD, LPC, discuss the benefits and disadvantages of using benzodiazepines, non-pharmacological alternative approaches, and the importance of informed…
August 21, 2019
Kathy Coleman, MSW, LCSW, ACSW, CAADC, milieu clinical coordinator for Pyramid Healthcare, discusses ethical issues regarding risk management, including being proactive in addressing the complexity…
August 21, 2019
Tom Meier, DBA, MBA, of NUWAY defines the concept of outcome-based compensation, explains how the system puts an emphasis on meeting clients' needs, and details how it works with staff at NUWAY.
August 19, 2019
This video includes presentations by: James Carroll, Director, Office of National Drug Control Policy; John Tilley, Secretary, Kentucky Justice and Public Safety Cabinet; John Martin, Assistant…
Back to Top